# ReShape Lifesciences Inc. (RSLS)

Source: https://www.quantisnow.com/company/RSLS
Generated: 2026-11-08T17:20:10.238Z

- Ticker: RSLS
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Medical/Dental Instruments
- IPO year: 2016
- Website: reshapelifesciences.com

## About

ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; and ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without cutting or permanently removing portions of the stomach, or bypassing any portion of the gastrointestinal tract. It also offers ReShapeCare virtual health coaching program, a virtual telehealth weight management program that supports healthy lifestyle changes for all medically managed weight-loss patients; and ReShape Diabetes Bloc-Stim Neuromodulation, a technology that is in preclinical development for the treatment of type 2 diabetes mellitus. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in October 2017. ReShape Lifesciences Inc. was incorporated in 2002 and is headquartered in San Clemente, California.

## Latest RSLS news and filings

- 2025-08-20 21:23 UTC [SEC Form 8-K] [ReShape Lifesciences Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits](https://www.quantisnow.com/insight/reshape-lifesciences-inc-filed-sec-form-8-k-entry-into-a-6173910)
- 2025-08-20 21:21 UTC [SEC Form 424B5] [SEC Form 424B5 filed by ReShape Lifesciences Inc.](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-reshape-lifesciences-inc-6173898)
- 2025-08-19 21:29 UTC [SEC Form 8-K] [ReShape Lifesciences Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits](https://www.quantisnow.com/insight/reshape-lifesciences-inc-filed-sec-form-8-k-completion-of-acquisition-6172277)
- 2025-08-14 23:18 UTC [Vyome closes Merger Transaction, Will Trade on Nasdaq as HIND Tomorrow](https://www.quantisnow.com/insight/vyome-closes-merger-transaction-will-trade-on-nasdaq-as-hind-6167437)
- 2025-08-14 21:20 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by ReShape Lifesciences Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-reshape-lifesciences-inc-6167138)
- 2025-08-13 15:50 UTC [Vyome Announces Nasdaq Approval of Merger with ReShape Lifesciences, Set to Begin Trading as HIND](https://www.quantisnow.com/insight/vyome-announces-nasdaq-approval-of-merger-with-reshape-lifesciences-set-6162560)
- 2025-08-12 13:48 UTC [Leadership Update] [Vyome Announces New Board of Directors with Deep MIT and AI Ties](https://www.quantisnow.com/insight/vyome-announces-new-board-of-directors-with-deep-mit-and-6160003)
- 2025-08-11 20:05 UTC [SEC Form 8-K] [ReShape Lifesciences Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders](https://www.quantisnow.com/insight/reshape-lifesciences-inc-filed-sec-form-8-k-submission-of-matters-6158281)
- 2025-08-07 21:01 UTC [ReShape Lifesciences Announces Shareholder Approval of Merger with Vyome Therapeutics](https://www.quantisnow.com/insight/reshape-lifesciences-announces-shareholder-approval-of-merger-with-vyome-therapeutics-6154701)
- 2025-07-30 17:28 UTC [SEC Form 425] [SEC Form 425 filed by ReShape Lifesciences Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-reshape-lifesciences-inc-6138216)
- 2025-07-25 20:08 UTC [SEC Form 425] [SEC Form 425 filed by ReShape Lifesciences Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-reshape-lifesciences-inc-6133034)
- 2025-07-25 20:06 UTC [SEC Form 8-K] [SEC Form 8-K filed by ReShape Lifesciences Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-reshape-lifesciences-inc-6133022)
- 2025-07-24 21:24 UTC [SEC Form 425] [SEC Form 425 filed by ReShape Lifesciences Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-reshape-lifesciences-inc-6132126)
- 2025-07-24 21:19 UTC [SEC Form 425] [SEC Form 425 filed by ReShape Lifesciences Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-reshape-lifesciences-inc-6132107)
- 2025-07-24 20:39 UTC [ReShape Lifesciences® Announces Partial Adjournment of Special Meeting of Stockholders](https://www.quantisnow.com/insight/reshape-lifesciences-announces-partial-adjournment-of-special-meeting-of-stockholders-6131935)
- 2025-07-22 12:31 UTC [ReShape Lifesciences® to Host Inaugural Lap-Band® Surgeon Summit](https://www.quantisnow.com/insight/reshape-lifesciences-to-host-inaugural-lap-band-surgeon-summit-6127770)
- 2025-07-21 20:20 UTC [SEC Form 425] [SEC Form 425 filed by ReShape Lifesciences Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-reshape-lifesciences-inc-6126881)
- 2025-07-21 18:10 UTC [ReShape Lifesciences® to Host Special Meeting of Stockholders on July 24, 2025](https://www.quantisnow.com/insight/reshape-lifesciences-to-host-special-meeting-of-stockholders-on-july-6126607)
- 2025-07-18 15:07 UTC [SEC Form 425] [SEC Form 425 filed by ReShape Lifesciences Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-reshape-lifesciences-inc-6125151)
- 2025-07-15 20:07 UTC [SEC Form 425] [SEC Form 425 filed by ReShape Lifesciences Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-reshape-lifesciences-inc-6120663)
- 2025-07-15 20:06 UTC [SEC Form 8-K] [ReShape Lifesciences Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/reshape-lifesciences-inc-filed-sec-form-8-k-regulation-fd-disclosure-6120658)
- 2025-07-03 20:05 UTC [SEC Form 8-K] [ReShape Lifesciences Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits](https://www.quantisnow.com/insight/reshape-lifesciences-inc-filed-sec-form-8-k-entry-into-a-6110915)
- 2025-07-01 12:31 UTC [ReShape Lifesciences® Granted U.S. Patent Related to an Intragastric Balloon System](https://www.quantisnow.com/insight/reshape-lifesciences-granted-us-patent-related-to-an-intragastric-balloon-6105037)
- 2025-06-27 13:01 UTC [ReShape Lifesciences® Regains Compliance with Nasdaq Minimum Stockholders Equity Requirement](https://www.quantisnow.com/insight/reshape-lifesciences-regains-compliance-with-nasdaq-minimum-stockholders-equity-requirement-6101442)
- 2025-06-26 17:03 UTC [SEC Form 425] [SEC Form 425 filed by ReShape Lifesciences Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-reshape-lifesciences-inc-6100202)
- 2025-06-26 12:31 UTC [ReShape Lifesciences® Announces Strategic Cost Reductions and Provides Update on the Merger Agreement with Vyome Therapeutics and Asset Purchase Agreement with Biorad Medisys](https://www.quantisnow.com/insight/reshape-lifesciences-announces-strategic-cost-reductions-and-provides-update-on-6099973)
- 2025-06-25 12:31 UTC [ReShape Lifesciences® Granted Key International Patent in Australia for Its Proprietary Diabetes Neuromodulation Technology](https://www.quantisnow.com/insight/reshape-lifesciences-granted-key-international-patent-in-australia-for-its-6098430)
- 2025-06-24 20:06 UTC [SEC Form 424B3] [SEC Form 424B3 filed by ReShape Lifesciences Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-reshape-lifesciences-inc-6097273)
- 2025-06-23 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by ReShape Lifesciences Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-reshape-lifesciences-inc-6094663)
- 2025-06-18 21:17 UTC [SEC Form 8-K] [ReShape Lifesciences Inc. filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/reshape-lifesciences-inc-filed-sec-form-8-k-other-events-6092325)
- 2025-06-17 01:32 UTC [SEC Form POS AM filed by ReShape Lifesciences Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-reshape-lifesciences-inc-6089027)
- 2025-06-13 20:05 UTC [SEC Form SCHEDULE 13G filed by ReShape Lifesciences Inc.](https://www.quantisnow.com/insight/sec-form-schedule-13g-filed-by-reshape-lifesciences-inc-6085716)
- 2025-06-12 20:18 UTC [SEC Form 8-K] [ReShape Lifesciences Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/reshape-lifesciences-inc-filed-sec-form-8-k-entry-into-a-6083790)
- 2025-06-12 12:25 UTC [ReShape Lifesciences® Signs Exclusive Distribution Agreement with Recon Supply to Access the VA and DoD Markets](https://www.quantisnow.com/insight/reshape-lifesciences-signs-exclusive-distribution-agreement-with-recon-supply-to-6083233)
- 2025-06-09 15:31 UTC [SEC Form 424B5] [SEC Form 424B5 filed by ReShape Lifesciences Inc.](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-reshape-lifesciences-inc-6077941)
- 2025-06-09 15:27 UTC [SEC Form 8-K] [ReShape Lifesciences Inc. filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/reshape-lifesciences-inc-filed-sec-form-8-k-other-events-6077936)
- 2025-06-09 13:00 UTC [Public Offering] [ReShape Lifesciences® Announces Pricing of $2.6 Million Public Offering](https://www.quantisnow.com/insight/reshape-lifesciences-announces-pricing-of-26-million-public-offering-6077799)
- 2025-06-06 20:10 UTC [SEC Form 424B3] [SEC Form 424B3 filed by ReShape Lifesciences Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-reshape-lifesciences-inc-6076336)
- 2025-06-03 12:31 UTC [Leadership Update] [ReShape Lifesciences® Announces EU MDR Certification for Entire European and United Kingdom Product Portfolio](https://www.quantisnow.com/insight/reshape-lifesciences-announces-eu-mdr-certification-for-entire-european-and-6069061)
- 2025-05-30 20:46 UTC [SEC Form 424B5] [SEC Form 424B5 filed by ReShape Lifesciences Inc.](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-reshape-lifesciences-inc-6065587)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/RSLS
- Earnings history: https://www.quantisnow.com/earnings/RSLS
- Dividend history: https://www.quantisnow.com/dividends/RSLS
- Insider transactions: https://www.quantisnow.com/insiders/RSLS
- Options chain: https://www.quantisnow.com/options/RSLS
- SEC 8-K filings only: https://www.quantisnow.com/company/RSLS/8-k
- RSS and alerts for RSLS: https://www.quantisnow.com/docs/rss-feeds.md